-
Je něco špatně v tomto záznamu ?
Down-regulation of JCAD Expression Attenuates Cardiomyocyte Injury by Regulating the Wnt/β-Catenin Pathway
C. Li, Z. Liu, D. Liu, H. Jiang, C. Bi, W. Shi
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
39692577
DOI
10.14712/fb2024070040229
Knihovny.cz E-zdroje
- MeSH
- apoptóza * účinky léků MeSH
- beta-katenin metabolismus MeSH
- buněčné linie MeSH
- down regulace * účinky léků MeSH
- kadheriny metabolismus MeSH
- kardiomyocyty * metabolismus účinky léků MeSH
- krysa rodu rattus MeSH
- peroxid vodíku * farmakologie MeSH
- proliferace buněk účinky léků MeSH
- signální dráha Wnt * účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Coronary heart disease (CHD) is one of the most commonly seen cardiovascular conditions across the globe. Junctional cadherin 5 associated (JCAD) protein is found in the intercellular junctions of endothelial cells and linked to cardiovascular diseases. Nonetheless, the influence of JCAD on cardiomyocyte injury caused by CHD is unclear. A model of H2O2-induced H9c2 cell injury was constructed, and JCAD mRNA and protein levels were assessed by qRT-PCR and Western blot. The impacts of JCAD on the proliferation or apoptosis of H9c2 cells were explored by CCK-8 assay, Western blot and TUNEL staining. The effect of JCAD on the inflammatory response and vascular endothelial function of H9c2 cells was detected using ELISA kits. The levels of Wnt/β-catenin pathway-related proteins were assessed by Western blot. H2O2 treatment led to a rise in the levels of JCAD in H9c2 cells. Over-expression of JCAD promoted H2O2-induced cellular injury, leading to notably elevated contents of inflammatory factors, along with vascular endothelial dysfunction. In contrast to over-expression of JCAD, silencing of JCAD attenuated H2O2-induced cellular injury and inhibited apoptosis, inflammatory response and vascular endothelial dysfunction. Notably, JCAD could regulate the Wnt/β-catenin pathway, while DKK-1, Wnt/β-catenin pathway antagonist, counteracted the enhancing impact of JCAD over-expression on H2O2-induced H9c2 cell injury, further confirming that JCAD acts by regulating the Wnt/β-catenin pathway. In summary, over-expression of JCAD promoted H2O2-induced H9c2 cell injury by activating the Wnt/β-catenin pathway, while silencing of JCAD attenuated the H2O2-induced cell injury.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25000293
- 003
- CZ-PrNML
- 005
- 20250110125103.0
- 007
- ta
- 008
- 250107s2024 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/fb2024070040229 $2 doi
- 035 __
- $a (PubMed)39692577
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Li, Can $u Dafeng People's Hospital of Yancheng City, Jiangsu Province, China
- 245 10
- $a Down-regulation of JCAD Expression Attenuates Cardiomyocyte Injury by Regulating the Wnt/β-Catenin Pathway / $c C. Li, Z. Liu, D. Liu, H. Jiang, C. Bi, W. Shi
- 520 9_
- $a Coronary heart disease (CHD) is one of the most commonly seen cardiovascular conditions across the globe. Junctional cadherin 5 associated (JCAD) protein is found in the intercellular junctions of endothelial cells and linked to cardiovascular diseases. Nonetheless, the influence of JCAD on cardiomyocyte injury caused by CHD is unclear. A model of H2O2-induced H9c2 cell injury was constructed, and JCAD mRNA and protein levels were assessed by qRT-PCR and Western blot. The impacts of JCAD on the proliferation or apoptosis of H9c2 cells were explored by CCK-8 assay, Western blot and TUNEL staining. The effect of JCAD on the inflammatory response and vascular endothelial function of H9c2 cells was detected using ELISA kits. The levels of Wnt/β-catenin pathway-related proteins were assessed by Western blot. H2O2 treatment led to a rise in the levels of JCAD in H9c2 cells. Over-expression of JCAD promoted H2O2-induced cellular injury, leading to notably elevated contents of inflammatory factors, along with vascular endothelial dysfunction. In contrast to over-expression of JCAD, silencing of JCAD attenuated H2O2-induced cellular injury and inhibited apoptosis, inflammatory response and vascular endothelial dysfunction. Notably, JCAD could regulate the Wnt/β-catenin pathway, while DKK-1, Wnt/β-catenin pathway antagonist, counteracted the enhancing impact of JCAD over-expression on H2O2-induced H9c2 cell injury, further confirming that JCAD acts by regulating the Wnt/β-catenin pathway. In summary, over-expression of JCAD promoted H2O2-induced H9c2 cell injury by activating the Wnt/β-catenin pathway, while silencing of JCAD attenuated the H2O2-induced cell injury.
- 650 12
- $a kardiomyocyty $x metabolismus $x účinky léků $7 D032383
- 650 12
- $a signální dráha Wnt $x účinky léků $7 D060449
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a peroxid vodíku $x farmakologie $7 D006861
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 12
- $a down regulace $x účinky léků $7 D015536
- 650 12
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a kadheriny $x metabolismus $7 D015820
- 650 _2
- $a beta-katenin $x metabolismus $7 D051176
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Liu, Zhengdong $u Dafeng People's Hospital of Yancheng City, Jiangsu Province, China
- 700 1_
- $a Liu, Dong $u Dafeng People's Hospital of Yancheng City, Jiangsu Province, China
- 700 1_
- $a Jiang, Hui $u Dafeng People's Hospital of Yancheng City, Jiangsu Province, China
- 700 1_
- $a Bi, Chenglong $u People's Hospital of Zibo City, Shandong Province, China
- 700 1_
- $a Shi, Weiwei $u Dafeng People's Hospital of Yancheng City, Jiangsu Province, China. dahuaxiyou820112@163.com
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 70, č. 4 (2024), s. 229-238
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39692577 $y Pubmed
- 910 __
- $a ABA008 $b A 970 $c 89 $y p $z 0
- 990 __
- $a 20250107 $b ABA008
- 991 __
- $a 20250110125055 $b ABA008
- 999 __
- $a ok $b bmc $g 2247178 $s 1236293
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 70 $c 4 $d 229-238 $e - $i 0015-5500 $m Folia biologica $n Folia Biol (Praha) $x MED00011004
- LZP __
- $b NLK138 $a Pubmed-20250107